Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2012
06/13/2012CN102498124A Cyclic amino acid molecules and methods of preparing the same
06/13/2012CN102498113A Macrocyclic inhibitors of jak
06/13/2012CN102498112A Process for preparing azabicyclic compounds
06/13/2012CN102498091A Glycine compound
06/13/2012CN102492140A Bi-phthalonitrile prepolymer as well as preparation method and application thereof, bi-phthalonitrile prepolymer/epoxy resin copolymer and preparation method thereof as well as bi-phthalonitrile prepolymer/epoxy resin cured material
06/13/2012CN102491978A Method for preparing natural pigments, polysaccharide and saponin by utilizing disused asparagus resources
06/13/2012CN102491977A 1-substituted benzene oxymethylene-8-alkylthio-10-methylthio pyrimido [5,4-e]-1,2,triazole [1,5-c] pyrimidine possessing herbicidal activity and its preparation method
06/13/2012CN102491976A 5-substituted-3,6-disubstituted-3,6-dihydro-7H-1,2,3-triazol[4,5-d]pyrimidine-7-ketone compounds having weeding activity and synthetic method thereof
06/13/2012CN102491975A Synthesis method for 5-trifluoromethyl-4, 7-dihydro-(1, 2, 4)-triazol (1, 5)-a pyrimidine derivative in ionic liquid
06/13/2012CN102491969A Heteroaromatic quinoline compounds
06/13/2012CN101415419B Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
06/13/2012CN101312977B Fused heterocyclic compounds useful as kinase modulators
06/13/2012CN101200468B Novel compounds and uses thereof
06/13/2012CN101198610B Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
06/13/2012CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/12/2012US8198448 Fused heterocyclic derivatives and methods of use
06/12/2012US8198438 Pyrrolotriazine kinase inhibitors
06/12/2012US8198433 Acylated phthalocyanines
06/12/2012US8198432 Porphyrin-based compounds for tumor imaging and photodynamic therapy
06/12/2012US8198431 Process for preparing triallyl isocyanurate (TAIC)
06/12/2012US8198288 Tetrahydropyrrolopyrimidinediones and their use in therapy
06/12/2012US8198281 Crystalline forms of dihydropyrazolopyrimidinone
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8197857 Method for eliminating carbon dioxide from waste gases
06/12/2012US8197819 Exposure of epitopes on envelop protein; complex of polypeptide and antigen; induce immunology response
06/12/2012CA2560897C Macrocyclic compounds as inhibitors of viral replication
06/07/2012WO2012075500A2 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
06/07/2012WO2012075393A2 Activators of proteasomal degradation and uses thereof
06/07/2012WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
06/07/2012WO2012075277A2 Synthetic methods
06/07/2012WO2012074180A1 Novel tetraazacyclododecan-tetraone derivative or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same for preventing or treating cancer
06/07/2012WO2012074135A1 Pyrimidine compound and use for pest control thereof
06/07/2012WO2012073143A1 Kat ii inhibitors
06/07/2012WO2012072036A1 Intermediates of sitagliptin and preparation process thereof
06/07/2012WO2012071684A1 Heterocyclic derivates，preparation processes and medical uses thereof
06/07/2012WO2012046254A3 Process for preparing an intermediate of sitagliptin via enzymatic conversion
06/07/2012WO2012042534A3 Preparation of r-sitagliptin and intermediates thereof
06/07/2012WO2012004258A9 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
06/07/2012US20120142913 Benzylidineanthracenone linked pyrrolobenzodiazepine hybrids useful as anticancer agents and process for the preparation thereof
06/07/2012US20120142912 Polycyclic compounds, termed calixurenes, and uses thereof
06/07/2012US20120142693 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin
06/07/2012US20120142681 Heterocyclic hydrazone compounds
06/07/2012US20120142679 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
06/07/2012US20120142672 Heterocyclic compound and use thereof
06/07/2012US20120142647 Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases
06/07/2012US20120142625 Substituted Purine And 7-Deazapurine Compounds
06/07/2012US20120141471 Methods of Inhibiting Metastasis from Cancer
06/07/2012CA2819648A1 Substituted purine and 7-deazapurine compounds
06/07/2012CA2819625A1 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
06/07/2012CA2819410A1 Heterocyclic derivates, preparation processes and medical uses thereof
06/07/2012CA2819333A1 Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
06/07/2012CA2819102A1 Kat ii inhibitors
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2460795A1 Fullerene derivatives
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459653A1 Phthalocyanines and naphthalocyanines with near-ir absorptions for inkjet inks
06/06/2012EP2459567A2 Phthalocyanine derivative consisting of a mixture of 4 isomers
06/06/2012EP2459566A1 Tricyclic inhibitors of jak
06/06/2012EP2459565A2 Methods and compositions for studying, imaging, and treating pain
06/06/2012EP2459564A2 Cyclopropyl modulators of p2y12 receptor
06/06/2012EP2459563A2 5-ht3 receptor modulators, methods of making, and use thereof
06/06/2012EP2459562A1 Pyrrolo [1, 2-b]pyridazine derivatives as janus kinase inhibitors
06/06/2012EP2459557A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
06/06/2012EP2459550A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/06/2012EP2459196A1 Plk inhibitor salts
06/06/2012EP2220092B1 Azaindolizines and methods of use
06/06/2012EP2137188B1 Substituted imidazopyrimidines and triazolopyrimidines
06/06/2012EP2029532B1 Piperazine enamines as antiviral agents
06/06/2012CN102485720A Heat shock protein 90 inhibitor
06/06/2012CN102485718A Sitagliptin intermediate and its preparation method
06/06/2012CN101973997B Method for preparing sitagliptin phosphate side chain
06/06/2012CN101921277B Method for simultaneously preparing vasicine and vasicinone from peganum harmala
06/06/2012CN101891748B Synthesis method of branched chain intermediate of biapenem
06/06/2012CN101568543B Macrocyclic peptides as hepatitis c virus inhibitors
06/06/2012CN101544649B Synthetic porous crystalline MCM-68, its synthesis and use
06/06/2012CN101039933B Diaminotriazole compounds useful as protein kinase inhibitors
06/05/2012US8193344 Process for making organic photosensitive pigment
06/05/2012US8193343 Manufacture and products thereof of photosensitizing nanomaterials and their use in photodynamic treatment
06/05/2012US8193202 LIMK2 inhibitors, compositions comprising them, and methods of their use
06/05/2012US8193199 Heterocyclic compounds and their uses
06/05/2012US8193191 Urotensin II receptor antagonists
06/05/2012US8193186 Pyridopyrazines and the use thereof as kinase inhibitors
06/05/2012US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits
06/05/2012US8193182 Substituted isoquinolin-1(2H)-ones, and methods of use thereof
06/05/2012US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/2012
05/31/2012WO2012070519A1 Organic electroluminescent element
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012070015A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
05/31/2012WO2012069852A1 Pharmaceutical compounds as inhibitors of sphingosine kinase
05/31/2012WO2012069380A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with phenyl derivatives
05/31/2012WO2012069202A1 Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
05/31/2012WO2012069121A1 Materials for organic electroluminescent devices
05/31/2012WO2012068622A1 Compounds for treating respiratory syncytial virus infections
05/31/2012WO2012037648A8 Process for chelating copper ions using cb-te2a bifunctional chelate
05/31/2012WO2012012712A3 Tricyclic proteasome activity enhancing compounds
05/31/2012US20120136024 3-Substituted-2-(arlyalkyl)-1-azabicycloalkanes and Methods of Use Thereof
05/31/2012US20120136013 Organic compounds
05/31/2012US20120135999 Compounds and methods for antiviral treatment
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 573